Clinical Trial Update: Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia

View source ↗

Summary

A completed trial update describing an education and awareness program to assess adherence to dyslipidemia treatment, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: AstraZeneca | Conditions: Patients With Dyslipidemia | Status: COMPLETED